• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

8

CATEGORIES

  • 15
  • 3
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1

PRICE

4
6
13
27

PUBLISHED

0
0
15
27

PRODUCT TYPE

21
6

Search "Viropro, Inc." returned 27 results.

PRODUCT TITLE

Viropro, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Project Synopsis: Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by...

June 2013
FROM
Viropro Inc.-Financial Company Report Viropro Inc.-Financial Company Report - Product Thumbnail Image

Viropro Inc.-Financial Company Report

Viropro Inc.-Financial Company Report contains the company’s contact information, details, business overview, shares information, stock performance history, price and volume figures, dividends, market...

March 2008
FROM
Viropro, Inc.,(VPRO) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages Viropro, Inc.,(VPRO) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

Viropro, Inc.,(VPRO) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Viropro, Inc. (VPRO), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

October 2013
FROM

Psoriatic Arthritis - Pipeline Review, H2 2013

Psoriatic Arthritis - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Psoriatic Arthritis - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This...

September 2013
FROM

Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H2 2013

Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H2 2013', provides an overview...

July 2013
FROM

Crohn's Disease - Pipeline Review, H2 2013

Crohn's Disease - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Crohn's Disease - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report...

August 2013
FROM

Ulcerative Colitis - Pipeline Review, H2 2013

Ulcerative Colitis - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Ulcerative Colitis - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This...

August 2013
FROM

Arthritis - Pipeline Review, H2 2013

Arthritis - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Arthritis - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information...

July 2013
FROM

Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H2 2013

Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H2 2013', provides an overview of the indication’s...

July 2013
FROM
Spectrum Pharmaceuticals, Inc. - Product Pipeline Review - 2013 Spectrum Pharmaceuticals, Inc. - Product Pipeline Review - 2013 - Product Thumbnail Image

Spectrum Pharmaceuticals, Inc. - Product Pipeline Review - 2013

Spectrum Pharmaceuticals, Inc. – Product Pipeline Review – 2013 Summary Global Market Direct’s pharmaceuticals report, “Spectrum Pharmaceuticals, Inc. - Product Pipeline Review - 2013” provides data...

April 2013
FROM
Competitor Analysis: Biosimilar and Biosuperior Therapeutic Antibodies Competitor Analysis: Biosimilar and Biosuperior Therapeutic Antibodies - Product Thumbnail Image

Competitor Analysis: Biosimilar and Biosuperior Therapeutic Antibodies

The present Competitive Intelligence Report about Biosimilar and Biosuperior Therapeutic Antibodies 2014 provides a competitor evaluation in the field of recombinant monoclonal and polyclonal antibodies...

March 2014
FROM

Biosimilars (2009 - 2014)

The impending expiry of several patented blockbuster biopharmaceuticals and the increasing demand from patients, insurers, and government agencies to reduce drug costs have created numerous opportunities...

September 2009
FROM

PharmaSphere: Global Biosimilars Strategy - Regulatory Landscape, Key Drivers, Markets and Trends in 2013

PharmaSphere: Global Biosimilars Strategy - Regulatory Landscape, Key Drivers, Markets and Trends in 2013 Summary Our "PharmaSphere: Global Biosimilars Strategy - Regulatory Landscape, Key Drivers,...

May 2013
FROM
Spectrum Pharmaceuticals, Inc. - Product Pipeline Review - 2012 Spectrum Pharmaceuticals, Inc. - Product Pipeline Review - 2012 - Product Thumbnail Image

Spectrum Pharmaceuticals, Inc. - Product Pipeline Review - 2012

Spectrum Pharmaceuticals, Inc. – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Spectrum Pharmaceuticals, Inc. - Product Pipeline Review - 2012” provides data...

May 2012
FROM
Human Vaccines - Global Strategic Business Report Human Vaccines - Global Strategic Business Report - Product Thumbnail Image

Human Vaccines - Global Strategic Business Report

This report analyzes the worldwide markets for Prophylatic Human Vaccines in US$ Million by the following Product Segments: Pediatric Prophylactic Vaccines and Adult Prophylactic Vaccines The report...

March 2012
FROM
Spectrum Pharmaceuticals, Inc. - Product Pipeline Review - H2 2011 Spectrum Pharmaceuticals, Inc. - Product Pipeline Review - H2 2011 - Product Thumbnail Image

Spectrum Pharmaceuticals, Inc. - Product Pipeline Review - H2 2011

Spectrum Pharmaceuticals, Inc. – Product Pipeline Review – H2 2011 Summary Global Market Direct’s pharmaceuticals report, “Spectrum Pharmaceuticals, Inc. - Product Pipeline Review - H2 2011” provides...

November 2011
FROM
Biosimilars and Biobetters: Positioning for a New Market Biosimilars and Biobetters: Positioning for a New Market - Product Thumbnail Image

Biosimilars and Biobetters: Positioning for a New Market

As regulatory frameworks for biosimilars development begin to take shape worldwide, there are growing opportunities for generics companies to enter the biologics market, a segment which is uniquely...

July 2009
Autoimmune Disease Therapeutics - Global Strategic Business Report Autoimmune Disease Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Autoimmune Disease Therapeutics - Global Strategic Business Report

This report analyzes the worldwide markets for Autoimmune Disease Therapeutics in US$ Million by the following Therapeutic Class: Rheumatoid Arthritis (Biologics), Multiple Sclerosis, Psoriasis, Crohns...

October 2011
FROM

Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H1 2014

Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H1 2014’, provides an overview of the Plaque...

February 2014
FROM

Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H1 2014

Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H1 2014’, provides an overview...

February 2014
FROM
Loading Indicator